TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax. Tyagi A, Jaggupilli A, Ly S, Yuan B, et al. Leukemia 2024;38:82-95.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tyagi A, Jaggupilli A, Ly S, Yuan B, et al. TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax. Leukemia 2024;38:82-95.
PMID: 38007585